![](/img/cover-not-exists.png)
Adjuvant Folfox4 with or without Cetuximab (CTX) in Patients (PTS) with Resected Stage III Colon Cancer (CC): Dfs and OS Results and Subgroup Analyses of the PETACC8 Intergroup Phase III Trial
Taieb, J., Tabernero, J., Mini, E., Subtil, F., Folprecht, G., Van Laethem, J., Thaler, J., Bridgewater, J.A., Van Cutsem, E.J.D., Rougier, P., Collette, L., Praet, M., Schneider, M., Bouché, O., LepVolume:
23
Journal:
Annals of Oncology
DOI:
10.1016/S0923-7534(20)34317-9
Date:
September, 2012
File:
PDF, 61 KB
2012